INTRODUCTION
In eukaryotes, amino acids act not only as building blocks of proteins but also as mediators of signal transduction for cell growth. The signaling function of amino acids, especially branched-chain amino acids such as leucine, is mainly mediated through mammalian target of rapamycin (mTOR), a Ser/Thr kinase conserved from yeast to mammals. mTOR interacts with raptor to form mTOR complex 1 (mTORC1) that regulates protein synthesis, cell growth, and autophagy in response to the availability of amino acids, glucose, and growth factors (Hara et al., 2002; Jung et al., 2010; Kim et al., 2002; Loewith et al., 2002) . Hyperactivation of mTORC1 has been identified in a number of human cancers including prostate cancer, multiple myeloma, and hamartoma syndromes, and impairment of mTOR regulation has also been linked to diabetes, obesity, and aging (Goberdhan and Boyd, 2009; Harrison et al., 2009; Selman et al., 2009; Um et al., 2004; Wullschleger et al., 2006) . Given the broad function of mTOR and its implication in many human diseases and physiological states, it is important to understand the mechanism underlying amino acid-dependent mTORC1 signaling.
Amino acids activate mTORC1 via Rag GTPases that are evolutionarily conserved in eukaryotes from yeast to mammals (Binda et al., 2009; Kim et al., 2008; Sancak et al., 2008) . Mammalian cells have four Rag GTPases: RagA, RagB, RagC, and RagD (Sekiguchi et al., 2001) . Rag GTPases are distinct from other small GTPases, as they form heterodimeric complexes consisting of RagA or RagB and RagC or RagD (Dubouloz et al., 2005; Hirose et al., 1998; Kim et al., 2008) . In yeast, Gtr1p and Gtr2p, which are orthologs of RagA and RagC, respectively, form a heterodimeric complex playing roles similar to those played by Rag GTPase complexes (Binda et al., 2009; Dubouloz et al., 2005) . The activity of Rag GTPase heterodimers depends on whether RagA and RagB are bound to GTP or GDP. The Rag GTPase complex containing GTP-bound RagA or RagB is active in stimulating mTORC1 in response to amino acids, whereas the complex containing GDP-bound RagA or RagB is inactive (Kim et al., 2008; Sancak et al., 2008) .
Several binding proteins of Rag GTPases were identified in recent studies. Ragulator is a lysosomal protein complex that binds and enables the Rag GTPase complex to recruit mTORC1 to the lysosomal membrane where mTORC1 is activated by Rheb GTPases (Sancak et al., 2010) . Ragulator was also shown to bind to vacuolar H(+)-adenosine triphosphatase (v-ATPase) that regulates Rag GTPases in response to amino acids in the lysosomal lumen (Zoncu et al., 2011) . In Drosophila, Rag GTPases interact with mitogen-activated protein 4 kinase 3 (MAP4K3) (Bryk et al., 2010) . In mammalian cells, MAP4K3 regulates mTORC1 in response to amino acids (Findlay et al., 2007; Yan et al., 2010) . Rag GTPases interact with p62 (SQSTM1), a ubiquitin-binding protein degraded by autophagy (Duran et al., 2011) . They also regulate mTORC1 localization to the TOR-autophagy spatial coupling compartment (TASCC) (Narita et al., 2011) , indicating an intimate crosstalk between the RagmTORC1 pathway and autophagy. Most recently, leucyl-tRNA synthetase (LRS) and its yeast homolog Cdc60 were found to 
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SH3BP4, a Negative Regulator of mTORC1 Signaling interact with RagD and Gtr1p, respectively, in mammalian cells and yeast in a leucine-dependent manner (Bonfils et al., 2012; Han et al., 2012) . LRS in mammalian cells was shown to function as a GTPase-activating protein (GAP) for RagD (Han et al., 2012) . In yeast, Vam6p was identified as a binding protein of Gtr1p and as a guanine nucleotide exchange factor (GEF) for Gtr1p (Binda et al., 2009) . Although these studies have provided important insight into the regulation of Rag GTPases, the molecular mechanisms by which amino acids regulate the activity of Rag GTPases remains not clearly understood.
In this study, we describe the discovery of a Rag GTPasebinding protein, SH3BP4, that negatively regulates Rag GTPase-mTORC1 signaling. We determined that SH3BP4 binds to the inactive Rag GTPase complex under leucine-deprived conditions and suppresses the formation of active Rag GTPase complex, thereby inhibiting mTORC1 signaling. We found that the inhibitory effect of SH3BP4 on mTORC1 signaling depends on the interaction between SH3BP4 and Rag GTPases that is mediated by the SH3 domain of SH3BP4. Based on these findings, we define SH3BP4 as a negative regulator of Rag GTPase complex and amino acid-dependent Rag GTPase-mTORC1 signaling.
RESULTS

Identification of SH3BP4 as a Rag GTPase-Binding Protein
To identify proteins that bind to Rag GTPases, we stably expressed flag-tagged RagB in HEK293T cells and isolated RagB-binding proteins by flag-affinity chromatography. Following our previously described procedure to prepare samples for mass spectrometry (Vander Haar et al., 2007 ) (see Fig- ure S1A online), we identified proteins that were specifically eluted with flag-tagged RagB. The pool of identified proteins contained RagC and RagD, confirming that our purification isolated the physiological binding partners of RagB. The pool also contained a protein called SH3BP4 or transferrin receptor-trafficking protein (TTP), a vertebrate-specific 963 amino acid protein that was previously shown to bind dynamin and epidermal growth factor receptor pathway substrate 15 (Eps15) and regulate endocytosis of transferrin receptor (TfR) (Tosoni et al., 2005) . This protein possesses one SH3 domain, three NPF motifs for binding the Eps15 homology domain, and putative binding sites for proteins involved in clathrin-mediated endocytosis ( Figure 1A ) (Dunlevy et al., 1999) . TTP is an acronym for a zinc finger protein tristetraprolin, and it has a function independent of TfR, as it becomes obvious from our study. Thus, the protein was named SH3BP4 throughout this manuscript, following the nomenclature by the HUGO Gene Nomenclature Committee.
SH3BP4 Preferentially Binds to GDP-Bound Forms of Rag GTPases SH3BP4 was coimmunopurified with either RagC or RagD, but not with cytosolic S6K1 or membrane-bound PA-PLA used as negative controls ( Figure 1B) . In a reciprocal manner, RagC was coimmunopurified with SH3BP4, but not with the control proteins ( Figure S1B ). To determine whether SH3BP4 can directly interact with Rag GTPases, we performed glutathione S-transferase (GST) pull-down assay using SH3BP4 and Rag GTPases purely prepared from bacteria. SH3BP4 was pulled down with GST-tagged RagC and RagD but barely with GSTtagged RagA and RagB ( Figure 1C ). This result suggests that SH3BP4 has a higher binding affinity toward the monomeric forms of RagC and RagD than those of RagA and RagB.
To assess the effects of the nucleotide-bound states of Rag GTPases on the interaction between SH3BP4 and Rag GTPases, we analyzed the binding affinity of SH3BP4 toward Rag GTPase mutants mimicking GTP-or GDP-bound states (Dubouloz et al., 2005; Gao and Kaiser, 2006; Hirose et al., 1998; Kim et al., 2008; Sancak et al., 2008; Sekiguchi et al., 2001) . RagB wild-type (WT) and its mutant mimicking the GTPbound state (RagB GTP ) did not bind to SH3BP4, whereas its mutant mimicking the GDP-bound state (RagB GDP ) was able to bind SH3BP4 ( Figure 1D and Figure S1C ). Like RagB GDP , RagA GDP was also able to bind to SH3BP4 ( Figure S1C ). This result suggests that SH3BP4 might bind only to the GDP-bound state of RagA and RagB, but not their GTP-bound states or uncharged states. By contrast, RagC interacted with SH3BP4 regardless of its nucleotide-bound status (WT, RagC GTP , and RagC GDP ) ( Figure 1D ). SH3BP4 showed a stronger binding affinity toward RagC GDP than either WT or RagC GTP , suggesting that GDP-bound states of both RagB and RagC are likely favored for binding by SH3BP4. Through in vitro analysis of the interaction between recombinant proteins purified from bacteria, we confirmed that RagB GDP can directly interact with SH3BP4 with an affinity comparable to that of the SH3BP4-RagC interaction ( Figure 1E ). Figure 1D ), they did not bind to SH3BP4 when they were coexpressed with RagB GTP ( Figure 1F and Figure S1D ). This result suggests that RagB GTP might have a negative effect on the binding of RagC or RagC GTP to SH3BP4. By contrast, RagC GDP interacted with SH3BP4 in RagB GTP -expressing cells ( Figure 1F and Figure S1D Figure 1G ). This result demonstrates that SH3BP4 may not form a stable interaction with the active Rag GTPase complexes.
On the other hand, all three forms of RagC (WT, RagC GTP , and RagC GDP ) were able to interact with SH3BP4 when they were coexpressed with RagB GDP ( Figure 1F and Figure S1D Figure 1H and Figures S1E-S1G). Taken together, these results suggest that SH3BP4 preferentially binds to inactive Rag GTPase complex.
SH3BP4 Binding to Rag GTPases Is Enhanced under Leucine-Deprived Conditions
If SH3BP4 preferentially binds to the inactive Rag GTPase complexes, we hypothesized that SH3BP4 binding to Rag GTPases might be increased under amino acid starvation. Since leucine is the most potent stimulator of mTORC1 signaling among amino acids (Kim et al., 2002) , we analyzed the interaction in the presence or absence of leucine in the medium. Supporting the hypothesis, leucine deprivation enhanced the amount of RagB recovered with SH3BP4 at endogenous levels ( Figure 2A ). The leucine deprivation-induced upregulation of interaction could be recapitulated by SH3BP4 and Rag GTPases overexpressed in HEK293T cells ( Figure 2B ). Leucine deprivation enhanced the interaction of SH3BP4 with RagB WT and RagB GDP but barely with RagB GTP . The amount of SH3BP4 bound to RagB GDP was much greater than that bound to RagB WT, as we would expect from the stronger binding affinity of SH3BP4 toward RagB GDP than RagB WT ( Figures 1D and 1E ). We further confirmed that the association of SH3BP4 with coexpressed RagB GDP and RagC GDP is gradually reduced by leucine at increasing concentrations in the medium ( Figure 2C ). These results suggest that the interaction of SH3BP4 with RagB GDP ,
but not with RagB GTP , is enhanced by leucine deprivation. The leucine-dependent interaction between SH3BP4 and RagB could be confirmed by fluorescence image analysis of GFP-SH3BP4 and mCherry-RagB in HeLa cells (Figure 2D and Figure S2) . Combined, these results consistently show that SH3BP4 binding to Rag GTPases is negatively regulated by leucine.
SH3BP4 Negatively Regulates Amino Acid-mTORC1 Signaling
Knowing that SH3BP4 preferentially binds to inactive Rag GTPase complex, we wondered if SH3BP4 regulates amino acid-mTORC1 signaling. We first investigated the effects of SH3BP4 knockdown on mTORC1 signaling in response to leucine in the medium. Knocking down SH3BP4 in HEK293T, HeLa, or MEFs induced a drastic increase in leucine-stimulated S6K1 phosphorylation at Thr389, the mTORC1-dependent phosphorylation site ( Figures 3A and 3B and Figure S3A ). The increase in the S6K1 phosphorylation occurred in a broad range of leucine concentrations in the medium ( Figure 3B ). The S6K1 phosphorylation was detected even in the absence of leucine in the medium when SH3BP4 was knocked down ( Figure S3A , lanes 1 and 7). The upregulation of S6K1 phosphorylation by SH3BP4 knockdown was corroborated by an increase in phosphorylation of 4E-BP1 at Ser65, another mTORC1 target site ( Figure 3A ). Consistent with the negative effect of SH3BP4 on mTORC1 signaling, either stable or transient overexpression of SH3BP4 almost completely suppressed the leucine-induced S6K1 and 4E-BP1 phosphorylation in HEK293T and HeLa cells ( Figure 3C and Figures S3B and S3C ). Since mTORC1 is activated not only by amino acids but also by insulin and glucose, we investigated a possibility that SH3BP4 might regulate mTORC1 through insulin-or glucosedependent signaling. Because mTORC1 cannot be fully activated if any signal derived from amino acids, glucose, or insulin is lacking (Fingar and Blenis, 2004; Sancak et al., 2008; Shamji et al., 2003) , we anticipated that SH3BP4 would also have inhibitory effects on insulin-and glucose-dependent mTORC1 signaling. As anticipated, insulin-stimulated S6K1 phosphorylation was enhanced by SH3BP4 knockdown and suppressed by SH3BP4 overexpression ( Figure S3D ). Neither knockdown nor overexpression of SH3BP4 affected the phosphorylation state of Akt at Ser473 ( Figure S3D ). SH3BP4 overexpression drastically inhibited S6K1 phosphorylation even in tuberous sclerosis complex 2 (TSC2)-silenced cells where mTORC1 is highly active ( Figure 3D ). Given that TSC2 functions in the Akt-mTORC1 pathway, this result suggests that SH3BP4 regulates mTORC1 in a manner independent of the Akt-TSC2 axis. We also found that glucose-stimulated S6K1 phosphorylation was enhanced by SH3BP4 knockdown and suppressed by SH3BP4 overexpression ( Figure S3E ). Neither knockdown nor overexpression of SH3BP4 affected the phosphorylation state of AMPK at Thr172, the indicator of AMPK activity ( Figure S3E ). The SH3BP4-RagB GDP interaction was regulated by leucine but by neither insulin nor glucose in the medium ( Figure 3E ), confirming that SH3BP4 has a specific effect on amino acid-dependent mTORC1 signaling.
We also considered a possibility that SH3BP4 might regulate mTORC1 through dynamin-dependent endocytosis of TfR based on the previously reported function of SH3BP4 (Tosoni et al., 2005) . Neither knockdown ( Figure 3F ) nor overexpression ( Figure S3F ) of TfR in HEK293T cells affected the leucinestimulated phosphorylation of S6K1. The leucine-stimulated phosphorylation of S6K1 was barely affected by deficiency of dynamin 1 and dynamin 2 in MEFs ( Figure 3G ) or only marginally by overexpression of dynamin 1 ( Figure S3G ). We also considered a possibility that SH3BP4 might regulate mTORC1 via altering amino acid uptake. Neither knockdown nor overexpression of SH3BP4 induced any significant change in amino acid uptake by HEK293T cells (Figures S3H and S3I ). These results suggest that SH3BP4 negatively regulates amino acid-mTORC1 signaling in a manner independent of TfR, dynamin, and amino acid uptake. A) SH3BP4 binding to RagB is negatively regulated by amino acids. HeLa cells were starved of leucine for 40 min and then supplemented with leucine at 104 mg/ml (+) or cultured further without leucine for 10 min (À). All other amino acids were present in the medium as described previously (Kim et al., 2002) . Endogenous SH3BP4 was isolated using anti-SH3BP4 antibody. The amount of endogenous RagB recovered with SH3BP4 was analyzed by WB. (B) SH3BP4 binding to RagB GDP is negatively regulated by amino acids. Myc-tagged RagB WT, RagB GTP , or RagB GDP was expressed with HA-SH3BP4 in HEK293T cells. Cells were treated with leucine as described in Figure 2A . The amount of HA-SH3BP4 recovered with myc-RagB was analyzed by WB. (C) SH3BP4 binding to the RagB GDP -RagC GDP complex was gradually reduced by increasing levels of leucine in the medium. HEK293T cells expressing myctagged RagB GDP and RagC GDP were treated with leucine (0, 1.04, 10.4, or 104 mg/ml) as described in Figure 2A . The amounts of Rag GTPases coimmunopurified with endogenous SH3BP4 were analyzed by WB.
(D) Leucine deprivation induces the colocalization of SH3BP4 with RagB. GFP-tagged SH3BP4 was coexpressed with mCherry-RagB in HeLa cells. Cells were treated with leucine as described in Figure 2A . The colocalization of SH3BP4 with RagB was analyzed by fluorescence microscope. Scale bar, 10 mm. 
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SH3BP4 Inhibits Cell Growth and Promotes Autophagy
Knowing that SH3BP4 binds to the inactive Rag GTPase complex and inhibits mTORC1 signaling, we investigated if SH3BP4 has negative effects on cell growth and proliferation.
Knockdown of SH3BP4 significantly enhanced proliferation rates of HEK293T and HeLa cells and increased mean size of HEK293T cells ( Figures 4A-4C and Figure S4 ). Consistently, overexpression of SH3BP4 in HEK293T cells dramatically (A) SH3BP4 knockdown enhanced amino acid-dependent mTORC1 signaling. HEK293T, HeLa, and MEFs stably transduced by SH3BP4 shRNA or scrambled shRNA were treated with leucine as described in Figure 2A . The levels of p-S6K1 (Thr389) and p-4E-BP1 (Ser65) in cell lysate were monitored by WB. (B) HEK293T cells stably transduced by shRNAs were treated with leucine at 0, 1.04, 5.2, 10.4, 52, or 104 mg/ml as described in Figure 2A . The level of p-S6K1 was analyzed by WB.
(C) Overexpression of SH3BP4 inhibited mTORC1 signaling. HEK293T and HeLa cells stably expressing myc-SH3BP4 were treated with leucine (0, 1.04, 10.4, or 104 mg/ml for HEK293T and 104 mg/ml for HeLa) as described in Figure 2A . The levels of p-S6K1 (Thr389) and p-4E-BP1 (Ser65) in cell lysate were analyzed by WB. (D) The negative effect of SH3BP4 on mTORC1 signaling is independent of TSC2. Myc-SH3BP4 and HA-S6K1 were expressed in TSC2-silenced or scrambled siRNA-transduced HEK293T cells. Cells were treated with leucine as described in Figure 2A . The level of p-S6K1 in HA immunoprecipitate was analyzed by WB.
(E) The SH3BP4-Rag interaction is regulated by leucine but by neither insulin nor glucose in the medium. HEK293T cells expressing myc-RagB GDP and HA-SH3BP4 were starved for leucine or glucose for 40 min and supplemented with leucine (104 mg/ml) or glucose (11 mM) for 10 min. Insulin (150 nM) was treated to cells and incubated for 1 hr after overnight serum starvation. The amount of HA-SH3BP4 recovered with myc-RagB GDP was analyzed by WB.
(F) TfR knockdown does not inhibit mTORC1 signaling in HEK293T cells. TfR-silenced cells were treated with leucine as described in Figure 2A . The level of p-S6K1 was monitored by WB.
(G) Deficiency of both dynamin 1 and dynamin 2 does not affect S6K1 phosphorylation in MEF cells. Dynamin 1-and dynamin 2-deficient MEFs were treated with leucine as described in Figure 2A . The level of p-S6K1 was monitored by WB.
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SH3BP4, a Negative Regulator of mTORC1 Signaling reduced cell proliferation rate ( Figure 4D ). We also investigated whether SH3BP4 has effects on autophagy, a process downstream of mTORC1 (Hosokawa et al., 2009; Jung et al., 2009 ). SH3BP4 overexpression increased the level of endogenous microtubule-associated protein 1 light chain 3-II (LC3-II) and the formation of LC3 puncta and reduced the expression level of p62 ( Figures 4E-4G ), all of which support an increase in autophagy (Mizushima and Yoshimori, 2007) . These results support the inhibitory function of SH3BP4 in the amino acidmTORC1 pathway.
SH3BP4 Inhibits Rag GTPase Binding to mTORC1, Thereby Suppressing mTORC1 Localization to Lysosome
Since SH3BP4 binds to Rag GTPase complex, it is logical to reason that the inhibitory effect of SH3BP4 on mTORC1 signaling might be mediated through Rag GTPase complex. If SH3BP4 inhibits mTORC1 via Rag GTPases, SH3BP4 knockdown would not have any positive effect on mTORC1 signaling in cells expressing the dominant-negative RagB GDP -RagC GTP complex. This was the case, as SH3BP4 knockdown did not increase S6K1 phosphorylation in cells expressing the inactive complex ( Figure 5A ). In line with this result, SH3BP4 overexpression did not inhibit mTORC1 signaling in cells expressing the constitutively active RagB GTP -RagC GDP complex ( Figure 5B ).
Combined, these results suggest that SH3BP4 negatively regulates mTORC1 signaling in a manner dependent upon the Rag GTPase complex. A previous study has shown that RagA GTP and RagB GTP , which form the active Rag GTPase complexes with RagC or RagD, bind to raptor and thereby recruit mTORC1 to the lysosome for mTORC1 activation (Sancak et al., 2010) . Since SH3BP4 inhibits mTORC1 via Rag GTPases, we considered a possibility that SH3BP4 might suppress the localization of mTORC1 to the lysosome. mTOR and LAMP1, a lysosomal marker, became colocalized when leucine was supplemented to the medium ( Figure 5C and Figure S5 ). The colocalization of mTOR and LAMP1 was suppressed in SH3BP4-overexpressing cells ( Figure 5C and Figure S5 ). Through coimmunoprecipitation analysis, we confirmed that SH3BP4 suppresses the interaction between raptor and Rag GTPases ( Figure 5D ). This result led us to propose a model wherein SH3BP4 inhibits mTORC1 signaling through suppression of the Rag GTPase-mTORC1 interaction on the lysosome.
SH3BP4 Binding to Rag GTPases through Its SH3 Domain Is Important for Inhibition of mTORC1 Signaling
Although the results above suggest that SH3BP4 inhibits mTORC1 via Rag GTPases, it remains to be determined whether the inhibitory effect depends on the binding of SH3BP4 to Rag GTPases. To address this question, we attempted to identify a point mutation on SH3BP4 that prevents SH3BP4 binding to Rag GTPases. We first delimited the region of SH3BP4 that is involved in binding to Rag GTPases. We found that N-terminal fragments of SH3BP4 containing the SH3 domain bind to RagB and RagC that are in the heterodimeric state ( Figure 6A ) or in the monomeric states ( Figure 6B ). Because Rag GTPases contain a PxxP motif that is known to participate in binding SH3 domain-containing proteins ( Figures S6A-S6D ), we predicted that the SH3 domain of SH3BP4 near the N terminus might be important for binding Rag GTPases. To test this possibility, we introduced a point mutation into the domain replacing Trp92 with alanine (W92A). Trp92 is located at a conserved position important for SH3 domain-specific interaction (Erpel et al., 1995; Musacchio et al., 1994; Panchamoorthy et al., 1994; Tosoni et al., 2005) . The mutation suppressed SH3BP4 (A) Myc-tagged RagB and RagC constructs were expressed with HA-S6K1 in scrambled shRNA-transduced or SH3BP4-silenced HEK293T cells. Cells were treated with leucine as described in Figure 2A . The level of p-S6K1 (Thr389) in HA immunoprecipitate was analyzed by WB.
(B) Myc-tagged RagB and RagC constructs were expressed with myc-SH3BP4 and HA-S6K1 in HEK293T cells. Cells were treated with leucine as described in Figure 2A . The level of p-S6K1 in HA immunoprecipitate was analyzed by WB. (C) SH3BP4 negatively regulates mTOR localization to the lysosome. GFP-tagged SH3BP4 or GFP alone (À) was transiently expressed in HeLa cells. Two days after the transfection, cells were treated with leucine as described in Figure 2A . Cells were stained using antibodies specific to mTOR (green) and LAMP1 (red) and visualized by confocal microscope. (Inset) Higher magnification demonstrates colocalization (yellow) of mTOR and LAMP1. Scale bar, 10 mm.
(D) SH3BP4 suppresses the interaction between Rag GTPases and raptor. HA-tagged raptor and SH3BP4 were coexpressed with myc-tagged RagB and RagC in HEK293T cells. The amount of HA-raptor coimmunopurified with myc-Rag GTPases was analyzed by WB.
Molecular Cell
SH3BP4, a Negative Regulator of mTORC1 Signaling (D) SH3BP4 W92A mutation impairs leucine-dependent regulation of SH3BP4-Rag GTPase interaction. HEK293T cells expressing SH3BP4 and RagB GDP as above in (C) were treated with leucine as described in Figure 2A . The amount of HA-SH3BP4 bound to myc-RagB GDP was analyzed.
(E and F) (E) Stable or (F) transient overexpression of SH3BP4 W92A mutant abolished the inhibitory effect of SH3BP4 on mTORC1. HEK293T cells were treated with leucine as described in Figure 2A , and the phosphorylation states of endogenous S6K1 and 4EBP1 (E) or myc-tagged S6K1 (F) were analyzed by WB. (G) W92A mutation blunts the inhibitory effect of SH3BP4 on cell proliferation. HEK293T cells stably transduced by mock vector or SH3BP4 constructs were analyzed for cell proliferation. Results are represented as mean ±SD (n = 6).
(H) W92A mutation suppresses the negative effect of SH3BP4 on cell growth. The mean ±SD cell diameters are 17.16 ± 0.08, 16.96 ± 0.09, and 17.10 ± 0.01 mm for mock, WT, and W92A cells, respectively. (I) W92A mutation suppresses the stimulatory effect of SH3BP4 on LC3 puncta formation in HeLa cells. GFP-LC3 puncta were analyzed as described in Figure 4F . Scale bar, 10 mm.
(J) Quantitative analysis of GFP-LC3 puncta per cell (*p < 0.05, **p < 0.01, n = 13). Mean value is shown as a horizontal bar.
SH3BP4, a Negative Regulator of mTORC1 Signaling binding to Rag GTPases ( Figure 6C and Figure S6E ), suggesting that the interaction depends on the SH3 domain. The interaction disrupted by W92A mutation was not recovered by leucine deprivation in the medium, the condition that strengthens the SH3BP4-Rag GTPase interaction ( Figure 6D ). This result suggests that the SH3 domain-mediated interaction is important for amino acid-responsive interaction between SH3BP4 and Rag GTPases. In order to test if the SH3 domain-mediated interaction is important for inhibition of mTORC1 signaling, we expressed SH3BP4 WT or W92A mutant stably or transiently in HEK293T cells and analyzed the phosphorylation state of S6K1 and 4EBP1. The interaction-disrupting W92A mutation suppressed the inhibitory effect of SH3BP4 on leucine-stimulated phosphorylation of S6K1 and 4E-BP1 (Figures 6E and 6F ). In line with this result, W92A mutation blunted the inhibitory effects of SH3BP4 on cell proliferation and growth ( Figures 6G and 6H ) and the stimulatory effect of SH3BP4 on the formation of LC3 puncta ( Figures  6I and 6J and Figure S6F ). Although we could not exclude a possibility that W92A mutation affects other unknown functions of SH3BP4, these results support our hypothesis that the SH3BP4-Rag GTPase interaction mediated by the SH3 domain is important for inhibition of mTORC1 signaling.
SH3BP4 Binding to Rag GTPases Inhibits the Formation of Active Rag GTPase Complex
The results above support our hypothesis that SH3BP4 binds to the inactive Rag GTPase complex under conditions of amino acid starvation and inhibits the activation of Rag GTPasemTORC1 signaling. A remaining question is how SH3BP4 binding inhibits the activity of the Rag GTPase complex. First, we wondered whether the inhibitory effect of SH3BP4 on mTOR localization to the lysosome can be attenuated by W92A mutation. SH3BP4 WT inhibited leucine-stimulated localization of mTOR to the lysosome, and this inhibitory effect was suppressed by W92A mutation ( Figure 7A and Figure S7A ). Consistent with this result, W92A mutation blunted the inhibitory effect of SH3BP4 on the interaction between raptor and Rag GTPases ( Figures 7B and 7C) . These results support our proposed model that the SH3 domain-dependent interaction between SH3BP4 and Rag GTPases is important to inhibit the raptor-Rag GTPase interaction and the recruitment of mTORC1 to the lysosome.
A possible mechanism for SH3BP4 to inhibit the raptor-Rag GTPase interaction might be through suppression of the formation of the active Rag GTPase complex. Given that SH3BP4 preferentially binds to the inactive Rag GTPase complex, we considered a possibility that SH3BP4 might inhibit the conversion of GDP-bound inactive forms of RagA/B to the GTP-bound active forms. Incubation of Rag GTPases with SH3BP4 WT in vitro resulted in suppression of GDP dissociation from Rag GTPases ( Figure 7D and Figures S7B and S7C ). The suppressive effect by SH3BP4 WT was almost completely abolished by SH3BP4 W92A mutation ( Figure 7D ). We also tested whether a fragment containing the N-terminal 300 amino acids of SH3BP4 that encompass the SH3 domain can suppress GDP dissociation from Rag GTPases. We found no significant effect with this fragment ( Figures S7D and S7E ), suggesting that a region of SH3BP4 other than the SH3 domain is required for the inhibitory effect. We predicted that the suppression of GDP dissociation should be accompanied by reduction in the GTP hydrolysis activity of Rag GTPases. As predicted, the incubation of RagB and RagC with SH3BP4 WT, but not W92A mutant, inhibited the GTP hydrolysis activity of Rag GTPases (Figures 7E and 7F and Figures S7F and S7G) . Consistent with this result, GTP loading onto RagB in response to amino acids was suppressed by SH3BP4 WT but not by SH3BP4 W92A ( Figure 7G ). In line with this, GTP loading onto RagB was increased by SH3BP4 knockdown ( Figure S7H ). Combined, these results support our proposed model that SH3BP4 binding to the inactive Rag GTPase complex impairs the formation of the active Rag GTPase complex ( Figure 7H ).
DISCUSSION
In this study, we define SH3BP4 as a binding protein of Rag GTPases and a negative regulator of amino acid-mTORC1 signaling. SH3BP4 directly binds to the inactive Rag GTPase complex under amino acid-starved conditions and inhibits the formation of the active complex. Consistent with this proposed mechanism, mTORC1 activity in SH3BP4-silenced cells was not completely inhibited in leucine-deprived conditions and was maintained at higher levels over a broad range of leucine concentrations in the medium compared to that in control cells ( Figure 3B and Figure S3A ). Such a function of SH3BP4 might contribute to reduction in the basal activity of mTORC1 or prevention of hyperactivation of mTORC1, and might be linked to cancer or other human diseases associated with hyperactive mTORC1 signaling. Consistent with this notion, analysis of human cancer genome databases revealed that deletions of the SH3BP4 locus are found in 10 of 14 cancer subtypes across 2,594 tumors (Table S1 ). Among the 10 subtypes, three subtypes (breast, renal, and non-small cell lung cancers) showed the highest frequency of deletions in the SH3BP4 locus with a statistical significance. Thus, SH3BP4 might be a potential candidate of tumor suppressor that functions in amino acid-Rag GTPasemTORC1 signaling.
Although our study provides strong evidence for the inhibitory effects of SH3BP4 on Rag GTPases, how it regulates Rag GTPases needs further investigation. According to our study ( Figures 2B and 2C ), SH3BP4 binding to Rag GTPases requires not only GDP charging of RagB but also an unknown process induced by amino acid starvation. It is noteworthy that RagC binding to SH3BP4 depends on the nucleotide-loaded states of RagB that is in a dimeric complex with RagC ( Figure 1F and Figure S1D ). This suggests that the dimeric interaction somehow affects the binding of SH3BP4 to Rag GTPases. Because the RagB GDP -RagC GDP complex could bind to SH3BP4 more strongly than the RagB GDP -RagC GTP complex ( Figure 1G ), SH3BP4 might bind to RagC GDP as well as RagB GDP in the complex. A detailed analysis of the stoichiometry of the interaction between Rag GTPases and SH3BP4 is necessary to better understand how they interact in the complex and how SH3BP4 inhibits Rag GTPases. We found that a high amount of Rag GTPases is isolated as a GTP-bound form under amino acid-starved conditions ( Figure 7G ). Recent reports have also shown a similar result (Duran et al., 2011; Sancak et al., 2008) . A possible explanation for such a high level of GTP-bound forms under amino acid starvation might be that Rag GTPases bound to GDP are unstable or immunopurified less efficiently compared to GTPbound forms. Alternatively, the affinity of GDP toward Rag GTPases might be lower than that of GTP in vitro, thus resulting in loss of the GDP-bound forms during in vitro isolation of Rag GTPases. Supporting this possibility, RagC was shown to bind GDP with a significantly lower affinity than GTP (Sekiguchi et al., 2001) . It is also possible that there might exist a population of Rag GTPases that are not regulated by amino acids.
Our in vitro assay of Rag GTPase activities revealed that SH3BP4 might not act as a GEF or a GAP for Rag GTPases (Figures 7D and 7E) . The in vitro assay also suggested that SH3BP4 inhibits Rag GTPases without requiring other molecules. The inhibitory function of SH3BP4 is similar to its previously identified function toward dynamin (Tosoni et al., 2005) . This implies that SH3BP4 might regulate multiple GTPases, at least including dynamin and Rag GTPases. Given that SH3BP4 functions are implicated in endocytosis and endosomal trafficking, it is tempting to speculate that the regulation of multiple GTPases by SH3BP4 might be important for a spatial and temporal coordination of endocytosis, vesicle trafficking, and mTOR localization in response to amino acids and other cellular signals.
How SH3BP4 regulates Rag GTPases in relation to Ragulator, v-ATPase, and LRS remains to be determined. Although SH3BP4 would not be a direct sensor of amino acids, conformational changes or posttranslational modifications may occur in either SH3BP4 or Rag GTPases to alter the interaction between SH3BP4 and Rag GTPases in response to amino acids. Supporting this notion, multiple phosphorylation sites have been reported for SH3BP4 (Chen et al., 2009; Chiba et al., 2009; Pan et al., 2008) . Those phosphorylations of SH3BP4 could potentially be an important mechanism for mTORC1 regulation by diverse intracellular signals as well as amino acids. Although the presence of SH3BP4 homologs in lower eukaryotes is not clear, it remains possible that a protein with a divergent sequence might exist in lower eukaryotes and play a similar role as that played by SH3BP4. Alternatively, SH3BP4 might have evolved to meet the greater regulatory complexity of higher eukaryotes. Further studies on the function of SH3BP4 may provide important insight into the regulatory mechanism of amino acidmTORC1 signaling.
EXPERIMENTAL PROCEDURES
Identification of RagB-Binding Proteins
Cell extract from HEK293T cells that stably express flag-tagged RagB was run through flag-affinity chromatography. The fraction that was bound to the column was trypsinized and analyzed by mass spectrometry. A detailed procedure is described in the Supplemental Experimental Procedures.
Plasmids
Human and mouse SH3BP4 cDNAs obtained from the ATCC (image number 2988648) and Open Biosystems (image number 4947387) were cloned into pRK5 expression vector by PCR amplification. Rag GTPase mutant constructs were generated by site-directed mutagenesis. pLKO.1 shRNA vector was used to knock down human or mouse SH3BP4. The target sequences are listed in the Supplemental Experimental Procedures.
Cell Image Analysis
The colocalization of proteins was analyzed by an Olympus FluoView 1000 IX2 inverted confocal microscope and a Deltavision Personal DV microscope (Applied Precision). A detailed procedure is described in the Supplemental Experimental Procedures.
In Vitro GDP Dissociation and GTPase Assay In vitro GDP dissociation and GTP hydrolysis assay were performed using Rag GTPases and SH3BP4 purified from bacteria and using [ 3 H]-GDP and [g 32 P]-GTP, respectively, as described in the Supplemental Experimental Procedures.
Other Experimental Procedures
Other experimental procedures, including materials, mass spectrometry, mutagenesis, coimmunoprecipitation, western blotting, lentiviral transduction, recombinant protein production, cell number and size measurement, autophagy assay, and analysis of genome from tumor samples, are described in the Supplemental Experimental Procedures.
